Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2010

01.11.2010 | Epidemiology

Predictors of breast cancer screening behavior in women with a strong family history of the disease

verfasst von: Melanie A. Price, Phyllis N. Butow, Margaret Charles, Tracey Bullen, Bettina Meiser, Joanne M. McKinley, Sue-Anne McLachlan, Kelly-Anne Phillips, kConFab Psychosocial and Clinical Follow-Up groups on behalf of the kConFab Investigators

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

This study applied the self-regulation model to examine cognitive and emotional predictors of screening in unaffected women with a strong family history of breast cancer. 748 unaffected female members of an Australian registry of multiple-case breast cancer families formed the sample. Participants completed a baseline psychosocial questionnaire and a screening questionnaire 3 years later. Multinomial logistic regression was employed to determine predictors of under- and over-screening according to national guidelines. At follow-up 16% of women under-screened and 10% over-screened with mammography; 55% under-screened with clinical breast examination (CBE); and 9% over-screened with breast self-examination (BSE). Of the women found screening according to guidelines for mammography 72% reported ever having received specific recommendations for mammography screening from a health professional. Compared to appropriate screeners, under-screeners on mammography were less likely to have received a screening recommendation (as were under-screeners on CBE), were younger and reported lower perceived breast cancer risk, but were at higher relative risk (RR) of breast cancer and were more likely to report elevated depression. Over-screeners on mammography were more likely to be younger and have a lower RR of breast cancer. Over-screeners on BSE reported elevated cancer-specific anxiety, were less likely to be university educated and more likely to have received a recommendation for BSE. Under- and over-screening is common in women with a strong family history of breast cancer. Evaluation of interventions targeting perceived risk of breast cancer, anxiety and depression are needed to ensure women obtain accurate advice from relevant specialists and enact screening recommendations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130CrossRefPubMed Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130CrossRefPubMed
2.
Zurück zum Zitat Phillips KA, Jenkins MA, Lindeman GJ et al (2006) Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet 70:198–206CrossRefPubMed Phillips KA, Jenkins MA, Lindeman GJ et al (2006) Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet 70:198–206CrossRefPubMed
3.
Zurück zum Zitat Antill YC, Reynolds J, Young MA et al (2006) Risk-reducing surgery in women with a familial susceptibility for breast and/or ovarian cancer. Eur J Cancer 42:621–628CrossRefPubMed Antill YC, Reynolds J, Young MA et al (2006) Risk-reducing surgery in women with a familial susceptibility for breast and/or ovarian cancer. Eur J Cancer 42:621–628CrossRefPubMed
4.
Zurück zum Zitat Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer 112:357–364CrossRefPubMed Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer 112:357–364CrossRefPubMed
5.
Zurück zum Zitat Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8876CrossRefPubMed Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8876CrossRefPubMed
6.
Zurück zum Zitat Australian Cancer Network (1999) Familial aspects of cancer: a guide to clinical practice. National Health and Medical Research Council. Commonwealth of Australia, Canberra Australian Cancer Network (1999) Familial aspects of cancer: a guide to clinical practice. National Health and Medical Research Council. Commonwealth of Australia, Canberra
7.
Zurück zum Zitat Vogel VG, Graves DS, Vernon SW et al (1990) Mammographic screening of women with increased risk of breast cancer. Cancer 66:1613–1620CrossRefPubMed Vogel VG, Graves DS, Vernon SW et al (1990) Mammographic screening of women with increased risk of breast cancer. Cancer 66:1613–1620CrossRefPubMed
8.
Zurück zum Zitat Antill YC, Reynolds J, Young MA et al (2006) Screening behavior in women at increased familial risk for breast cancer. Fam Cancer 5:359–368CrossRefPubMed Antill YC, Reynolds J, Young MA et al (2006) Screening behavior in women at increased familial risk for breast cancer. Fam Cancer 5:359–368CrossRefPubMed
9.
Zurück zum Zitat Katapodi MC, Lee KA, Facione NC et al (2004) Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38:388–402CrossRefPubMed Katapodi MC, Lee KA, Facione NC et al (2004) Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38:388–402CrossRefPubMed
10.
Zurück zum Zitat Leventhal H, Cameron L (1987) Behavioral theories and the problem of compliance. Patient Educat Couns 10:117–136CrossRef Leventhal H, Cameron L (1987) Behavioral theories and the problem of compliance. Patient Educat Couns 10:117–136CrossRef
11.
Zurück zum Zitat Dawson SJ, Price MA, Jenkins MA et al (2008) Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. J Clin Oncol 26:225–232CrossRefPubMed Dawson SJ, Price MA, Jenkins MA et al (2008) Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. J Clin Oncol 26:225–232CrossRefPubMed
12.
Zurück zum Zitat Phillips KA, Butow PN, Stewart AE et al (2005) Predictors of participation in clinical and psychosocial follow up of the kConFab breast cancer family study. Fam Cancer 4:105–123CrossRefPubMed Phillips KA, Butow PN, Stewart AE et al (2005) Predictors of participation in clinical and psychosocial follow up of the kConFab breast cancer family study. Fam Cancer 4:105–123CrossRefPubMed
14.
Zurück zum Zitat Mann GJ, Thorne H, Balleine RL et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12CrossRefPubMed Mann GJ, Thorne H, Balleine RL et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12CrossRefPubMed
15.
Zurück zum Zitat Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111–1130CrossRefPubMed Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111–1130CrossRefPubMed
16.
Zurück zum Zitat Meiser B, Butow P, Barratt A et al (1999) Attitudes to prophylactic oophorectomy and screening utilization in women at risk of developing hereditary breast/ovarian cancer. Gynecolc Oncol 75:122–129CrossRef Meiser B, Butow P, Barratt A et al (1999) Attitudes to prophylactic oophorectomy and screening utilization in women at risk of developing hereditary breast/ovarian cancer. Gynecolc Oncol 75:122–129CrossRef
17.
Zurück zum Zitat Horowitz M, Wilner N, Alverez MA (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41:209–218PubMed Horowitz M, Wilner N, Alverez MA (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41:209–218PubMed
18.
Zurück zum Zitat Thewes B, Meiser B, Hickie I (2001) Psychometric properties of the impact of event scale among women at increased risk for hereditary breast cancer. Psychooncology 10:459–468CrossRefPubMed Thewes B, Meiser B, Hickie I (2001) Psychometric properties of the impact of event scale among women at increased risk for hereditary breast cancer. Psychooncology 10:459–468CrossRefPubMed
19.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
20.
Zurück zum Zitat Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self mastery, and self esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 67:1063–1078CrossRefPubMed Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self mastery, and self esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 67:1063–1078CrossRefPubMed
21.
Zurück zum Zitat Broadhead WE, Gehbach SH, de Gruy FV et al (1988) The Duke-UNC functional social support questionnaire. Med Care 26:709–723CrossRefPubMed Broadhead WE, Gehbach SH, de Gruy FV et al (1988) The Duke-UNC functional social support questionnaire. Med Care 26:709–723CrossRefPubMed
22.
Zurück zum Zitat Lerman C, Daly M, Sands C et al (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–1080CrossRefPubMed Lerman C, Daly M, Sands C et al (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–1080CrossRefPubMed
23.
Zurück zum Zitat Meiser B, Butow P, Barratt A et al (2000) Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 59:101–111CrossRefPubMed Meiser B, Butow P, Barratt A et al (2000) Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 59:101–111CrossRefPubMed
24.
Zurück zum Zitat Isaacs C, Peshkin BN, Schwartz M et al (2002) Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71:103–112CrossRefPubMed Isaacs C, Peshkin BN, Schwartz M et al (2002) Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71:103–112CrossRefPubMed
25.
Zurück zum Zitat Schwartz MD, Taylor KL, Willard KS (2003) Prospective association between distress and mammography utilization among women with a family history of breast cancer. J Behav Med 26:105–118CrossRefPubMed Schwartz MD, Taylor KL, Willard KS (2003) Prospective association between distress and mammography utilization among women with a family history of breast cancer. J Behav Med 26:105–118CrossRefPubMed
26.
Zurück zum Zitat Tinley ST, Houfek J, Watson P et al (2004) Screening adherence in BRCA1/2 families is associated with primary physicians’ behavior. Am J Med Genet 125A:5–11CrossRefPubMed Tinley ST, Houfek J, Watson P et al (2004) Screening adherence in BRCA1/2 families is associated with primary physicians’ behavior. Am J Med Genet 125A:5–11CrossRefPubMed
27.
Zurück zum Zitat Lerman C, Kash K, Stefanek M (1994) Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Instit Monographs 16:171–176 Lerman C, Kash K, Stefanek M (1994) Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Instit Monographs 16:171–176
28.
Zurück zum Zitat Epstein A, Lin TH, Audrain J et al (1997) Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. High-Risk Breast Cancer Consortium. Psychosomatics 38:253–261PubMed Epstein A, Lin TH, Audrain J et al (1997) Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. High-Risk Breast Cancer Consortium. Psychosomatics 38:253–261PubMed
29.
Zurück zum Zitat Marteau TM, Weinman J (2006) Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 62:1360–1368CrossRefPubMed Marteau TM, Weinman J (2006) Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 62:1360–1368CrossRefPubMed
30.
Zurück zum Zitat Gooding HC, Organista K, Burack J et al (2006) Genetic susceptibility testing from a stress and coping perspective. Soc Sci Med 62:1880–1890CrossRefPubMed Gooding HC, Organista K, Burack J et al (2006) Genetic susceptibility testing from a stress and coping perspective. Soc Sci Med 62:1880–1890CrossRefPubMed
31.
Zurück zum Zitat Shiloh S (2006) Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns 15:325–337CrossRefPubMed Shiloh S (2006) Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns 15:325–337CrossRefPubMed
32.
Zurück zum Zitat Cockburn J, Irwig L, Turnbull D et al (1989) Encouraging attendance at screening mammography: knowledge, attitudes and intentions of general practitioners. Med J Aust 151:391–396PubMed Cockburn J, Irwig L, Turnbull D et al (1989) Encouraging attendance at screening mammography: knowledge, attitudes and intentions of general practitioners. Med J Aust 151:391–396PubMed
Metadaten
Titel
Predictors of breast cancer screening behavior in women with a strong family history of the disease
verfasst von
Melanie A. Price
Phyllis N. Butow
Margaret Charles
Tracey Bullen
Bettina Meiser
Joanne M. McKinley
Sue-Anne McLachlan
Kelly-Anne Phillips
kConFab Psychosocial and Clinical Follow-Up groups on behalf of the kConFab Investigators
Publikationsdatum
01.11.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0868-1

Weitere Artikel der Ausgabe 2/2010

Breast Cancer Research and Treatment 2/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.